# Shalin Shah - CEO of Marius Pharmaceuticals on the oral TRT partnership with Hims

Page: https://stenobird.com/podcast/hims-house-7026583/shalin-shah-ceo-of-marius-pharmaceuticals-on-the-oral-trt-partnership-with-hims
Text version: https://stenobird.com/podcast/hims-house-7026583/shalin-shah-ceo-of-marius-pharmaceuticals-on-the-oral-trt-partnership-with-hims.md
Podcast: [Hims House](https://stenobird.com/podcast/hims-house-7026583)
Published: 2025-11-10T14:27:55+00:00
Episode link: https://podcasters.spotify.com/pod/show/jonathan-stern1/episodes/Shalin-Shah---CEO-of-Marius-Pharmaceuticals-on-the-oral-TRT-partnership-with-Hims-e3egqke
Audio file: https://anchor.fm/s/10e9c0874/podcast/play/114894926/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-1-2%2F417288005-44100-2-8a5bf478189186cd.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/shalin-shah-ceo-of-marius-pharmaceuticals-on-the-oral-trt-partnership-with-hims
Duration seconds: 1955

## Resource

Shalin Shah is the founder & CEO of Marius Pharmaceuticals, the company that partnered with $HIMS to launch oral testosterone (KYZATREX). We discuss how the partnership came about, the benefits of teaming up with $HIMS, and the future of TRT. (00:41) Origin of the partnership (02:55) Benefits of partnering with $HIMS (04:14) Deal shape and exclusivity (06:51) How KYZATREX will sit alongside compounded meds on the $HIMS platform (09:22) Will KYZATREX be personalized? (16:07) TRT as a schedule 3 substance (21:39) Gearing up for 2026 launch of KYZATREX (22:40) Future of TRT market (27:29) Peptides (29:44) Testosterone for females Get full access to Hims House at himshouse.substack.com/subscribe

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/hims-house-7026583/episodes/shalin-shah-ceo-of-marius-pharmaceuticals-on-the-oral-trt-partnership-with-hims/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/hims-house-7026583/shalin-shah-ceo-of-marius-pharmaceuticals-on-the-oral-trt-partnership-with-hims.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.